{"id":"https://openalex.org/W4388588574","doi":"https://doi.org/10.1093/neuonc/noad179.0425","title":"DDDR-32. EVALUATING THE THERAPEUTIC EFFECTS OF SMALL MOLECULE INHIBITORS OF CDK4/6 AND FAK IN PRECLINICAL MENINGIOMA MODELS","display_name":"DDDR-32. EVALUATING THE THERAPEUTIC EFFECTS OF SMALL MOLECULE INHIBITORS OF CDK4/6 AND FAK IN PRECLINICAL MENINGIOMA MODELS","publication_year":2023,"publication_date":"2023-11-01","ids":{"openalex":"https://openalex.org/W4388588574","doi":"https://doi.org/10.1093/neuonc/noad179.0425"},"language":"en","primary_location":{"id":"doi:10.1093/neuonc/noad179.0425","doi":"https://doi.org/10.1093/neuonc/noad179.0425","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noad179.0425","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/25/Supplement_5/v112/53254360/noad179.0425.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/neuro-oncology/article-pdf/25/Supplement_5/v112/53254360/noad179.0425.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081881863","display_name":"Nazanin Ijad","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nazanin Ijad","raw_affiliation_strings":["Massachusetts General Hospital , Boston , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital , Boston , USA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068180184","display_name":"Katie L. Waller","orcid":"https://orcid.org/0009-0004-2275-4062","observed_orcids":["https://orcid.org/0009-0004-2275-4062"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katie Waller","raw_affiliation_strings":["Mayo Clinic , Rochester , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic , Rochester , USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025986307","display_name":"Naema Nayyar","orcid":"https://orcid.org/0000-0003-3436-8404","observed_orcids":["https://orcid.org/0000-0003-3436-8404"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Naema Nayyar","raw_affiliation_strings":["Massachusetts General Hospital , Boston , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital , Boston , USA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012959798","display_name":"Erika Yamazawa","orcid":"https://orcid.org/0000-0002-3079-2331","observed_orcids":["https://orcid.org/0000-0002-3079-2331"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erika Yamazawa","raw_affiliation_strings":["Massachusetts General Hospital , Boston, MA , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital , Boston, MA , USA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032028131","display_name":"Elizabeth Summers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth Summers","raw_affiliation_strings":["Massachusetts General Hospital , Boston , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital , Boston , USA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092071860","display_name":"Christian Migliarese","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christian Migliarese","raw_affiliation_strings":["Massachusetts General Hospital , Boston, MA , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital , Boston, MA , USA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017494786","display_name":"Evanthia Galanis","orcid":"https://orcid.org/0000-0001-8014-786X","observed_orcids":["https://orcid.org/0000-0001-8014-786X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Evanthia Galanis","raw_affiliation_strings":["Mayo Clinic , Rochester , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic , Rochester , USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015247761","display_name":"Jann Nagina Sarkaria","orcid":"https://orcid.org/0000-0001-7489-4885","observed_orcids":["https://orcid.org/0000-0001-7489-4885"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jann Sarkaria","raw_affiliation_strings":["Mayo Clinic , Rochester , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic , Rochester , USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032385201","display_name":"Rachael A. Vaubel","orcid":"https://orcid.org/0000-0001-8842-5975","observed_orcids":["https://orcid.org/0000-0001-8842-5975"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rachael Vaubel","raw_affiliation_strings":["Mayo Clinic , Rochester , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic , Rochester , USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006633218","display_name":"Hiroaki Wakimoto","orcid":"https://orcid.org/0000-0001-8225-241X","observed_orcids":["https://orcid.org/0000-0001-8225-241X"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hiroaki Wakimoto","raw_affiliation_strings":["Harvard Medical School , Boston, MA , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harvard Medical School , Boston, MA , USA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5015428519","display_name":"Priscilla Kaliopi Brastianos","orcid":"https://orcid.org/0000-0003-4470-8425","observed_orcids":["https://orcid.org/0000-0003-4470-8425"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Priscilla Brastianos","raw_affiliation_strings":["Massachusetts General Hospital/Harvard Medical School , Boston, MA , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital/Harvard Medical School , Boston, MA , USA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4612,"currency":"USD","value_usd":4612},"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.22032692,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"25","issue":"Supplement_5","first_page":"v112","last_page":"v113"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11251","display_name":"Meningioma and schwannoma management","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11251","display_name":"Meningioma and schwannoma management","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10975","display_name":"Bone Tumor Diagnosis and Treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/meningioma","display_name":"meningioma","score":0.9850000143051147},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.9559999704360962},{"id":"https://openalex.org/keywords/fak-inhibitors","display_name":"FAK inhibitors","score":0.8769999742507935},{"id":"https://openalex.org/keywords/raf-mek-inhibitors","display_name":"RAF/MEK inhibitors","score":0.9890000224113464},{"id":"https://openalex.org/keywords/abemaciclib","display_name":"abemaciclib","score":0.9860000014305115},{"id":"https://openalex.org/keywords/defactinib","display_name":"defactinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/vs-4718","display_name":"VS-4718","score":0.9819999933242798},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.875},{"id":"https://openalex.org/keywords/synthetic-lethality","display_name":"synthetic lethality","score":0.746999979019165},{"id":"https://openalex.org/keywords/cdkn2a-loss","display_name":"CDKN2A loss","score":0.9309999942779541},{"id":"https://openalex.org/keywords/neurofibromatosis-type-2","display_name":"neurofibromatosis type 2","score":0.7329999804496765},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.9509999752044678},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.9660000205039978},{"id":"https://openalex.org/keywords/orthotopic-xenograft-model","display_name":"orthotopic xenograft","score":0.7540000081062317},{"id":"https://openalex.org/keywords/matrigel","display_name":"Matrigel","score":0.6790000200271606},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.7870000004768372}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7142688632011414},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6663309931755066},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6329705715179443},{"id":"https://openalex.org/C2780265364","wikidata":"https://www.wikidata.org/wiki/Q5009957","display_name":"CDKN2A","level":3,"score":0.516193687915802},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.5061880946159363},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5004973411560059},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.48195740580558777},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.4538884460926056},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.4486890733242035},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3750911056995392},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.317546546459198},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.28609248995780945},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.16909533739089966},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1542070508003235},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.13835877180099487},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.06293544173240662},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1093/neuonc/noad179.0425","doi":"https://doi.org/10.1093/neuonc/noad179.0425","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noad179.0425","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/25/Supplement_5/v112/53254360/noad179.0425.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10639343","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10639343","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10639343/pdf/noad179.0425.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro Oncol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/neuonc/noad179.0425","doi":"https://doi.org/10.1093/neuonc/noad179.0425","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noad179.0425","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/25/Supplement_5/v112/53254360/noad179.0425.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4388588574.pdf","grobid_xml":"https://content.openalex.org/works/W4388588574.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4308976879","https://openalex.org/W4404230577","https://openalex.org/W4416141194","https://openalex.org/W7202353362","https://openalex.org/W4286717404","https://openalex.org/W7154481401","https://openalex.org/W6989146015","https://openalex.org/W3038977817","https://openalex.org/W2978520257","https://openalex.org/W4393095310"],"abstract_inverted_index":{"Abstract":[0],"BACKGROUND":[1],"New":[2],"therapies":[3,65,275,294],"are":[4,11,144,299],"needed":[5],"for":[6,271],"meningioma":[7,105,134,263,285],"since":[8],"treatment":[9],"options":[10],"limited":[12],"once":[13],"patients":[14,159],"have":[15],"exhausted":[16],"surgery":[17],"and":[18,22,36,59,63,68,72,79,92,98,126,148,151],"radiation.":[19],"FAK,":[20,57],"CDK4/6":[21,58],"RAF/MEK":[23,60],"represent":[24],"potential":[25],"targets":[26],"because":[27],"of":[28,34,38,47,55,119,124,175,195,202,207,234,273],"synthetic":[29],"lethality":[30],"with":[31,111,160,177,220,254,287],"NF2,":[32],"loss":[33],"CDKN2A,":[35],"activation":[37],"MAPK":[39],"signaling":[40],"pathway":[41],"in":[42,66,99,130,139,180,184,217,276,283,295],"meningioma,":[43],"respectively.":[44],"The":[45,117,200],"objective":[46],"this":[48],"study":[49],"was":[50,197],"to":[51,84,188,291],"evaluate":[52,292],"the":[53,104,173,193,205],"efficacy":[54,118,282],"targeting":[56],"as":[61,96,230,232],"monotherapies":[62],"combination":[64,174,194,233],"traditional":[67],"patient-derived":[69,149],"cell":[70,77,146,150,185],"lines":[71],"xenografts.":[73],"METHODS":[74],"In":[75,169,211],"vitro,":[76],"viability":[78,186],"proliferation":[80],"assays":[81],"were":[82,109,128],"used":[83],"test":[85],"abemaciclib":[86,127,178,221,237],"(CDK4/6":[87],"inhibitor),":[88],"defactinib":[89,176],"(FAK":[90],"inhibitor)":[91,95],"VS-6766":[93],"(RAF/MEK":[94],"monotherapy":[97,190],"combination.":[100],"To":[101],"better":[102],"recapitulate":[103],"microenvironment,":[106],"targeted":[107],"agents":[108],"evaluated":[110,129],"Matrigel,":[112],"an":[113,261],"artificial":[114],"extracellular":[115],"matrix.":[116],"VS-4718":[120,235,255],"(in":[121],"vivo":[122],"formulation":[123],"defactinib)":[125],"a":[131,181,266],"subcutaneous":[132],"IOMM-lee":[133],"model":[135],"(having":[136],"CDKN2A":[137,288],"loss)":[138],"nude":[140],"mice.":[141],"Furthermore,":[142],"we":[143,213,258],"establishing":[145],"cultures":[147],"xenograft":[152],"(PDX)":[153],"models":[154,298],"using":[155,265],"freshly-resected":[156],"tissue":[157],"from":[158],"recurrent":[161],"or":[162],"high-grade":[163],"(WHO":[164],"grade":[165],"2-3)":[166],"meningiomas.":[167],"RESULTS":[168],"vitro":[170],"evaluation":[171,272],"identified":[172],"resulted":[179],"synergistic":[182],"decrease":[183],"relative":[187],"each":[189],"alone,":[191],"while":[192],"defactinib+VS-6766":[196],"not":[198,250],"beneficial.":[199],"presence":[201],"Matrigel":[203],"enhanced":[204],"sensitivity":[206],"all":[208],"three":[209],"agents.":[210],"vivo,":[212],"observed":[214],"improved":[215],"survival":[216,252],"mice":[218],"treated":[219],"vs":[222,226,238,242],"control":[223,239],"(45":[224],"days":[225,241],"26":[227,243],"days;":[228,244],"p=0.03),":[229],"well":[231],"+":[236],"(44":[240],"p=0.04,":[245],"Gehan-Breslow-Wilcoxon":[246],"test).":[247],"We":[248],"did":[249],"observe":[251],"extension":[253],"monotherapy.":[256],"Lastly,":[257],"successfully":[259],"established":[260],"orthotopic":[262,297],"PDX":[264],"WHO":[267],"Grade":[268],"3":[269],"tumor":[270],"novel":[274],"meningioma.":[277],"CONCLUSION":[278],"Abemaciclib":[279],"showed":[280],"promising":[281],"preclinical":[284],"xenografts":[286],"loss.":[289],"Studies":[290],"these":[293],"other":[296],"underway.":[300]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-11-12T00:00:00"}